178 related articles for article (PubMed ID: 26296515)
1. Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes.
Rodríguez Cruz PM; Palace J; Ramjattan H; Jayawant S; Robb SA; Beeson D
Neurology; 2015 Sep; 85(12):1043-7. PubMed ID: 26296515
[TBL] [Abstract][Full Text] [Related]
2. Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7.
Lashley D; Palace J; Jayawant S; Robb S; Beeson D
Neurology; 2010 May; 74(19):1517-23. PubMed ID: 20458068
[TBL] [Abstract][Full Text] [Related]
3. Salbutamol therapy in congenital myasthenic syndrome due to DOK7 mutation.
Lorenzoni PJ; Scola RH; Kay CS; Filla L; Miranda AP; Pinheiro JM; Chaouch A; Lochmüller H; Werneck LC
J Neurol Sci; 2013 Aug; 331(1-2):155-7. PubMed ID: 23790237
[TBL] [Abstract][Full Text] [Related]
4. DOK7 congenital myasthenic syndrome.
Palace J
Ann N Y Acad Sci; 2012 Dec; 1275():49-53. PubMed ID: 23278577
[TBL] [Abstract][Full Text] [Related]
5. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
[TBL] [Abstract][Full Text] [Related]
6. [Treatment approach to congenital myasthenic syndrome in a patient with acetylcholine receptor deficiency].
Ishigaki K; Murakami T; Ito Y; Yanagisawa A; Kodaira K; Shishikura K; Suzuki H; Hirayama Y; Osawa M
No To Hattatsu; 2009 Jan; 41(1):37-42. PubMed ID: 19172815
[TBL] [Abstract][Full Text] [Related]
7. Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.
Burke G; Hiscock A; Klein A; Niks EH; Main M; Manzur AY; Ng J; de Vile C; Muntoni F; Beeson D; Robb S
Neuromuscul Disord; 2013 Feb; 23(2):170-5. PubMed ID: 23219351
[TBL] [Abstract][Full Text] [Related]
8. Ephedrine treatment for autoimmune myasthenia gravis.
Lipka AF; Vrinten C; van Zwet EW; Schimmel KJ; Cornel MC; Kuijpers MR; Hekster YA; Weinreich SS; Verschuuren JJ
Neuromuscul Disord; 2017 Mar; 27(3):259-265. PubMed ID: 28007405
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcomes in patients with congenital myasthenic syndromes.
O'Connell K; Rooney T; Alabaf S; Ramdas S; Beeson D; Palace J
Muscle Nerve; 2022 Sep; 66(3):345-348. PubMed ID: 35661384
[TBL] [Abstract][Full Text] [Related]
10. Distinct phenotypes of congenital acetylcholine receptor deficiency.
Burke G; Cossins J; Maxwell S; Robb S; Nicolle M; Vincent A; Newsom-Davis J; Palace J; Beeson D
Neuromuscul Disord; 2004 Jun; 14(6):356-64. PubMed ID: 15145336
[TBL] [Abstract][Full Text] [Related]
11. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
[TBL] [Abstract][Full Text] [Related]
12. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
Andreux F; Hantaï D; Eymard B
Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
[TBL] [Abstract][Full Text] [Related]
13. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients.
Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S
Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638
[TBL] [Abstract][Full Text] [Related]
14. Positive response to inhaled salbutamol in congenital myasthenic syndrome due to CHRNE mutation.
Garg D; Goyal V
Muscle Nerve; 2022 Jul; 66(1):E1-E2. PubMed ID: 35466404
[No Abstract] [Full Text] [Related]
15. Beneficial effect of albuterol in congenital myasthenic syndrome with epsilon-subunit mutations.
Sadeh M; Shen XM; Engel AG
Muscle Nerve; 2011 Aug; 44(2):289-91. PubMed ID: 21721016
[TBL] [Abstract][Full Text] [Related]
16. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and Dok-7 myasthenia.
Liewluck T; Selcen D; Engel AG
Muscle Nerve; 2011 Nov; 44(5):789-94. PubMed ID: 21952943
[TBL] [Abstract][Full Text] [Related]
18. Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol.
Finlayson S; Spillane J; Kullmann DM; Howard R; Webster R; Palace J; Beeson D
Muscle Nerve; 2013 Feb; 47(2):279-82. PubMed ID: 23281026
[TBL] [Abstract][Full Text] [Related]
19. Congenital myasthenic syndrome: a tale of two siblings.
Banerjee A; Datta Kanjilal S; Biswas T; Ghoshal A; Sarkar S
Int J Neurosci; 2024 Jun; 134(3):253-255. PubMed ID: 36018836
[TBL] [Abstract][Full Text] [Related]
20. Myasthenia gravis in a woman with congenital AChR deficiency due to epsilon-subunit mutations.
Croxen R; Vincent A; Newsom-Davis J; Beeson D
Neurology; 2002 May; 58(10):1563-5. PubMed ID: 12034803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
